BIG LOTS INC (BIG)

US0893021032 - Common Stock

3.64  -0.06 (-1.62%)

After market: 3.66 +0.02 (+0.55%)

Fundamental Rating

1

BIG gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 34 industry peers in the Broadline Retail industry. Both the profitability and financial health of BIG have multiple concerns. BIG has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year BIG has reported negative net income.
In the past year BIG has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: BIG reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: BIG reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -14.49%, BIG is doing worse than 84.85% of the companies in the same industry.
Looking at the Return On Equity, with a value of -169.38%, BIG is doing worse than 87.88% of the companies in the same industry.
Industry RankSector Rank
ROA -14.49%
ROE -169.38%
ROIC N/A
ROA(3y)-5.22%
ROA(5y)1.5%
ROE(3y)-59.77%
ROE(5y)-20.28%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 35.72%, BIG is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
BIG's Gross Margin has declined in the last couple of years.
BIG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.93%
GM growth 5Y-2.49%

1

2. Health

2.1 Basic Checks

BIG does not have a ROIC to compare to the WACC, probably because it is not profitable.
BIG has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BIG has less shares outstanding
BIG has a worse debt/assets ratio than last year.

2.2 Solvency

BIG has a Debt/Equity ratio of 1.43. This is a high value indicating a heavy dependency on external financing.
BIG has a Debt to Equity ratio of 1.43. This is in the lower half of the industry: BIG underperforms 72.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC13.02%

2.3 Liquidity

BIG has a Current Ratio of 1.31. This is a normal value and indicates that BIG is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.31, BIG is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
A Quick Ratio of 0.16 indicates that BIG may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.16, BIG is doing worse than 96.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.16

1

3. Growth

3.1 Past

BIG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -90.24%.
Looking at the last year, BIG shows a very negative growth in Revenue. The Revenue has decreased by -13.64% in the last year.
BIG shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.05% yearly.
EPS 1Y (TTM)-90.24%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q0%
Revenue 1Y (TTM)-13.64%
Revenue growth 3Y-8.67%
Revenue growth 5Y-2.05%
Revenue growth Q2Q-7.17%

3.2 Future

BIG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.56% yearly.
Based on estimates for the next years, BIG will show a decrease in Revenue. The Revenue will decrease by -0.80% on average per year.
EPS Next Y11.13%
EPS Next 2Y18.58%
EPS Next 3Y17.56%
EPS Next 5YN/A
Revenue Next Year-5.08%
Revenue Next 2Y-2.48%
Revenue Next 3Y-0.8%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

BIG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BIG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as BIG's earnings are expected to grow with 17.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.58%
EPS Next 3Y17.56%

0

5. Dividend

5.1 Amount

BIG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BIG LOTS INC

NYSE:BIG (4/22/2024, 7:04:00 PM)

After market: 3.66 +0.02 (+0.55%)

3.64

-0.06 (-1.62%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap106.36M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.49%
ROE -169.38%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 35.72%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.42
Health
Industry RankSector Rank
Debt/Equity 1.43
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.31
Quick Ratio 0.16
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-90.24%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y11.13%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-13.64%
Revenue growth 3Y-8.67%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y